Stock data
Novartis$105.85
NOVN 
0.65% • 24 H
0.65% • 24 HDividend Yield:3.3%
Global Rank#48
Market Cap$217.57B
YTD Performance9.70%
P/E0
Revenue$46.66B
Change 7d4.57%
SP500 BenchmarkUnderperform
Country🇨🇭 Switzerland
P/S4.66
Earnings$14.85B
Dividend Yield:3.3%
Main Sector
Healthcare
Novartis NOVN Total Debt
NOVN Total Debt in 2022: $20.03B
According to Novartis latest financial reports the total debt is $20.03B, an decrease of -8.02% to 2022. At the end of 2022 company had $21.78B total debt. This figure represents the debts and financial obligations that Novartis combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Novartis NOVN Total Debt History from 2023 to 2022
-
Value:-
NOVN Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $20.03B | -8.02% |
| 2022 | $21.78B | -11.18% |
| 2021 | $24.52B | -12.35% |
| 2020 | $27.98B | 26.85% |
| 2019 | $22.06B | -1.84% |
| 2018 | $22.47B | - |
View the Top Total Debt Stocks 
